Bette, Stefanie
Ruhland, Julia M.
Wiestler, Benedikt
Barz, Melanie
Meyer, Bernhard
Zimmer, Claus
Ryang, Yu-Mi
Ringel, Florian
Gempt, Jens
Article History
Received: 16 July 2018
Accepted: 15 May 2019
First Online: 10 June 2019
Competing Interests
: C.Z. has served on scientific advisory boards for Philips and Bayer Schering; serves as co-editor on the Advisory Board of Clinical Neuroradiology; has received speaker honoraria from Bayer-Schering and Philips and has received research support and investigator fees for clinical studies from Biogen Idec, Quintiles, MSD Sharp & Dome, Boehringer Ingelheim, Inventive Health Clinical UK Ltd., Advance Cor, Brainsgate, Pfizer, Bayer-Schering, Novartis, Roche, Servier, Penumbra, WCT GmbH, Syngis, SSS Internartional Clinical Research, PPD Germany GmbH, Worldwide Clinical Trials Ltd., Phenox, Covidien, Actelion, Medivation, Medtronic, Harrison Clinical Research, Concentric, Penumbra, Pharmtrace, Reverse Medical Corp., Premier Research Germany Ltd., Surpass Medical Ltd. and GlaxoSmithKline. S.B., J.G., and B.M. work as consultants for Brainlab (Brainlab AG, Munich). All named potential conflicts of interest are unrelated to this study. B.W. received funding from KKF TU Munich. This funding is unrelated to this study. This study received no financial support. This work was supported by the German Research Foundation (DFG) and the Technical University of Munich (TUM) in the framework of the Open Access Publishing Program